Skip to main content
Log in

Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Glutathione S-transferase T1 (GSTT1) polymorphic variation has been implicated as a risk factor for various cancers. However, previous studies investigating the association between GSTT1 null genotype and laryngeal cancer risk in Asians reported conflicting outcomes. In the present study, the possible association of laryngeal cancer risk with GSTT1 null genotype was explored by a meta-analysis. Relevant studies were identified through a systemic search of PubMed and Chinese National Knowledge Infrastructure databases. Six studies with a total of 1,824 individuals were included in the meta-analysis. The pooled odds ratio (OR) with 95 % confidence interval (CI) was used to assess the association. Meta-analysis of all included studies showed that there was an obvious association between GSTT1 null genotype and laryngeal cancer risk in Asians (OR = 2.41, 95 % CI 1.27–4.57, P = 0.007, I 2 = 86 %). After adjusting for heterogeneity, there was still an obvious association between GSTT1 null genotype and laryngeal cancer risk in Asians (OR = 1.75, 95 % CI 1.36–2.24, P < 0.001, I 2 = 0 %). The findings from the meta-analysis suggest that GSTT1 null genotype is associated with laryngeal cancer risk in Asians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Beitler JJ, Muller S, Grist WJ, Corey A, Klein AM, Johns MM, et al. Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol. 2010;28:2318–22.

    Article  PubMed  Google Scholar 

  3. Wolf GT. Routine computed tomography scanning for tumor staging in advanced laryngeal cancer: implications for treatment selection. J Clin Oncol. 2010;28:2315–7.

    Article  PubMed  Google Scholar 

  4. Sasaki CT, Jassin B. Cancer of the pharynx and larynx. Am J Med. 2001;111(Suppl 8A):118S–23.

    Article  PubMed  Google Scholar 

  5. Manjarrez ME, Ocadiz R, Valle L, Pacheco C, Marroquin A, De la Torre C, et al. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors. Clin Cancer Res. 2006;12:6946–51.

    Article  CAS  PubMed  Google Scholar 

  6. Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, btg2, by mir-21 in human laryngeal carcinoma. Cell Res. 2009;19:828–37.

    Article  CAS  PubMed  Google Scholar 

  7. Ying XJ, Dong P, Shen B, Xu CZ, Xu HM, Zhao SW. Glutathione S-transferase m1 gene polymorphism and laryngeal cancer risk: a meta-analysis. PLoS One. 2012;7:e42826.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Lacko M, Voogd AC, Roelofs HM, Te Morsche RH, Ophuis MB, Peters WH, et al. Combined effect of genetic polymorphisms in phase I and II biotransformation enzymes on head and neck cancer risk. Head Neck. 2013;35:858–67.

    Article  PubMed  Google Scholar 

  9. Oakley A. Glutathione transferases: a structural perspective. Drug Metab Rev. 2011;43:138–51.

    Article  CAS  PubMed  Google Scholar 

  10. Sharma R, Yang Y, Sharma A, Awasthi S, Awasthi YC. Antioxidant role of glutathione S-transferases: protection against oxidant toxicity and regulation of stress-mediated apoptosis. Antioxid Redox Signal. 2004;6:289–300.

    Article  CAS  PubMed  Google Scholar 

  11. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154–66.

    Article  CAS  PubMed  Google Scholar 

  12. Hong YJ, Lee JK, Lee GH, Hong SI. Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med. 2000;38:917–9.

    Article  CAS  PubMed  Google Scholar 

  13. Li Q, Wang L, Chen Y, Du Y, Kong P, Li Y, et al. Polymorphisms of gstm1, gstt1 and susceptibility of laryngeal and hypopharyngeal carcinomas. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2009;23:1105–7. 1111.

    PubMed  Google Scholar 

  14. Nosheen M, Ishrat M, Malik FA, Baig RM, Kayani MA. Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: a case control study. Asian Pac J Cancer Prev. 2010;11:881–5.

    CAS  PubMed  Google Scholar 

  15. Ruwali M, Singh M, Pant MC, Parmar D. Polymorphism in glutathione S-transferases: susceptibility and treatment outcome for head and neck cancer. Xenobiotica. 2011;41:1122–30.

    Article  CAS  PubMed  Google Scholar 

  16. Tian S, Zhang J, Xiao Q, Zhai J, Yan X, Huang M, et al. [The association between genetic polymorphisms of gstm1, gstt1, gstp1 and susceptibility to laryngeal carcinoma from the Han people in Guangdong zone]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;25:204–10.

    CAS  PubMed  Google Scholar 

  17. Masood N, Kayani MA. Protection against laryngeal and pharyngeal carcinoma: heterozygous vs. homozygous deletions of GSTM1 and GSTT1. Genet Mol Biol. 2013;36:1–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Ying XJ, Dong P, Shen B, Wang J, Wang S, Wang G. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. J Cancer Res Clin Oncol. 2011;137:1661–7.

    Article  CAS  PubMed  Google Scholar 

  23. Dong G, Tian Y, Chen S, Xu X, Zheng J, Li T. Glutathione S-transferase T1 null genotype is associated with oral cancer susceptibility in Asian populations. Tumour Biol. 2013;34:1753–7.

    Article  CAS  PubMed  Google Scholar 

  24. Zhao Y, Luo Y, Huang B, Qin B, Zhang T, Zhang J, et al. Gstt1 null genotype contributes to increased risk of gastric cancer in Chinese population: evidence from a meta-analysis. Tumour Biol. 2013;34:1691–7.

    Article  CAS  PubMed  Google Scholar 

  25. Ying XJ, Xu CZ, Xu HM, Sun ZF, Zhang J, Wang GL, et al. Lack of association between glutathione S-transferase T1 gene polymorphism and laryngeal cancer susceptibility: a meta-analysis based on 2,124 cases and 2,059 controls. Gene. 2012;494:11–6.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are indebted to the authors of the primary studies.

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ming Liu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Q., Liu, M. Glutathione S-transferase T1 null genotype and laryngeal cancer risk: a meta-analysis. Tumor Biol. 35, 8781–8785 (2014). https://doi.org/10.1007/s13277-014-2121-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-2121-8

Keywords

Navigation